We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ICH Moves Forward with Revising Its Pediatric Drug Guideline
ICH Moves Forward with Revising Its Pediatric Drug Guideline
The International Council for Harmonisation identified the key scientific issues facing drug developers in pediatric indications in a draft updating its 16-year-old E11 guideline.